0.888

0.91% 0.008

Kronos Bio Inc (KRON)

Overview News Price History Option Chain Financials Discussions Forecast

Kronos Bio Inc stock is traded at $0.888, with a volume of 11,027. It is up +0.91% in the last 24 hours and down -6.41% over the past month. Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Previous Close:

$0.88

Open:

$0.8956

24h Volume:

11,027

Relative Volume:

0.06

Market Cap:

$52.29M

Revenue:

Net Income/Loss:

$-112.67M

P/E Ratio:

-0.4554

EPS:

-1.95

Net Cash Flow:

$-79.26M

1W Performance:

+14.18%

1M Performance:

-6.41%

6M Performance:

-4.52%

1Y Performance:

-14.62%

1-Day Range:

$0.85

$0.899

1-Week Range:

$0.7701

$0.92

52-Week Range:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name

Kronos Bio Inc

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

(650) 781-5200

Address

1300 S. EL CAMINO REAL, SAN MATEO

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

KRON's Discussions on Twitter

Compare KRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KRON Kronos Bio Inc	0.888	52.29M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Downgrade	Piper Sandler	Overweight → Neutral
Nov-14-24	Downgrade	TD Cowen	Buy → Hold
Sep-14-22	Initiated	Berenberg	Buy
Oct-20-21	Resumed	Cowen	Outperform
Jun-24-21	Initiated	H.C. Wainwright	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Goldman	Buy
Nov-03-20	Initiated	Jefferies	Buy
Nov-03-20	Initiated	Piper Sandler	Overweight

View All

Kronos Bio Inc Stock (KRON) Latest News

Apr 11, 2025

Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia

Apr 11, 2025

Apr 10, 2025

Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com South Africa

Apr 10, 2025

Kronos Bio Announces Lease Termination Agreement - TipRanks

Apr 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times

Apr 10, 2025

Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025

Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025

Mar 25, 2025

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 25, 2025

Mar 20, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025

Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Mar 18, 2025